共 106 条
[1]
Gobburu JV(2010)Pharmacometrics 2020 J Clin Pharmacol 50 151S-157S
[2]
Karlsson MO(1995)Three new residual error models for population PK/PD analyses J Pharmacokinet Biopharm 23 651-672
[3]
Beal SL(2009)The impact of misspecification of residual error or correlation structure on the type I error rate for covariate inclusion J Pharmacokinet Pharmacodyn 36 81-99
[4]
Sheiner LB(2000)Using heteroscedasticity consistent standard errors in the linear regression model J Am Stat 54 217-224
[5]
Silber HE(1989)Models for longitudinal data with random effects and AR(1) errors J Am Stat Assoc 84 452-459
[6]
Kjellsson MC(1993)Some general estimation methods for nonlinear mixed effects models J Biopharm Stat 3 23-55
[7]
Karlsson MO(2015)A strategy for residual error modeling incorporating scedasticity of variance and distribution shape J Pharmacokinet Pharmacodyn 43 137-151
[8]
Long JS(1964)An analysis of transformations J R Stat Soc B 26 211-252
[9]
Ervin LH(1998)Assumption testing in population pharmacokinetic models: illustrated with an analysis of Moxonidine data from congestive heart failure patients J Pharmacokinet Biopharm 26 207-246
[10]
Chi EM(2013)Basic concepts in population modeling, simulation, and model-based drug development. Part 2: introduction to pharmacokinetic modeling methods CPT Pharmacometrics Syst Pharmacol 2 e38-2197